Controlled release of nalbuphine propionate from biodegradable microspheres: In vitro and in vivo studies

Shu Yang Yen, K. C. Sung, Jhi Joung Wang, Oliver Yoa-Pu Hu

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The objective of this work was to assess the in vitro characteristics, in vivo pharmacokinetics and in vivo pharmacodynamics of nalbuphine propionate (NAP)-loaded microspheres. An oil-in-water solvent evaporation method was used to incorporate NAP into poly (d,l-lactide-co-glycolide) (PLGA)-based microspheres. The morphology of the microspheres were evaluated using scanning electron microscopy which showed a spherical shape with smooth surface. A prolonged in vitro drug release profile was observed, with ∼71.1% of incorporated drug released in 96 h. The release profile fit well to the Baker and Lonsdale's spherical matrix model, suggesting the release of NAP from microspheres was consistent with a diffusion mechanism. The in vivo pharmacokinetic studies after subcutaneous injection of NAP-loaded microsphere showed a sustained plasma nalbuphine (NA)-time profile, with 100% relative bioavailability comparing to the AUC obtained after intravenous injection. The in vitro release pattern correlated well with the in vivo pharmacokinetic profile. The pharmacodynamic studies evaluated using paw pressure model also showed a prolonged pharmacological response after injection of microspheres. A linear correlation between the percent analgesic effect and the logarithm of plasma NA concentration was obtained, suggesting the pharmacological response can be reflected by plasma drug concentration. This correlation may be utilized for evaluating the pharmacological responses of various NA and its prodrug-based formulations with known plasma NA concentrations.

Original languageEnglish
Pages (from-to)91-99
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume220
Issue number1-2
DOIs
Publication statusPublished - Jun 4 2001
Externally publishedYes

Fingerprint

Nalbuphine
Propionates
Microspheres
Pharmacokinetics
Pharmacology
In Vitro Techniques
Prodrugs
Subcutaneous Injections
Intravenous Injections
Pharmaceutical Preparations
Electron Scanning Microscopy
Biological Availability
Area Under Curve
Analgesics
Oils
Pressure
Injections

Keywords

  • Controlled release
  • Microsphere
  • Nalbuphine propionate
  • Poly (d,l-lactide-co-glycolide)

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Controlled release of nalbuphine propionate from biodegradable microspheres : In vitro and in vivo studies. / Yen, Shu Yang; Sung, K. C.; Wang, Jhi Joung; Yoa-Pu Hu, Oliver.

In: International Journal of Pharmaceutics, Vol. 220, No. 1-2, 04.06.2001, p. 91-99.

Research output: Contribution to journalArticle

Yen, Shu Yang ; Sung, K. C. ; Wang, Jhi Joung ; Yoa-Pu Hu, Oliver. / Controlled release of nalbuphine propionate from biodegradable microspheres : In vitro and in vivo studies. In: International Journal of Pharmaceutics. 2001 ; Vol. 220, No. 1-2. pp. 91-99.
@article{2bda9cef756c49449fb31dbf0eb8c6ac,
title = "Controlled release of nalbuphine propionate from biodegradable microspheres: In vitro and in vivo studies",
abstract = "The objective of this work was to assess the in vitro characteristics, in vivo pharmacokinetics and in vivo pharmacodynamics of nalbuphine propionate (NAP)-loaded microspheres. An oil-in-water solvent evaporation method was used to incorporate NAP into poly (d,l-lactide-co-glycolide) (PLGA)-based microspheres. The morphology of the microspheres were evaluated using scanning electron microscopy which showed a spherical shape with smooth surface. A prolonged in vitro drug release profile was observed, with ∼71.1{\%} of incorporated drug released in 96 h. The release profile fit well to the Baker and Lonsdale's spherical matrix model, suggesting the release of NAP from microspheres was consistent with a diffusion mechanism. The in vivo pharmacokinetic studies after subcutaneous injection of NAP-loaded microsphere showed a sustained plasma nalbuphine (NA)-time profile, with 100{\%} relative bioavailability comparing to the AUC obtained after intravenous injection. The in vitro release pattern correlated well with the in vivo pharmacokinetic profile. The pharmacodynamic studies evaluated using paw pressure model also showed a prolonged pharmacological response after injection of microspheres. A linear correlation between the percent analgesic effect and the logarithm of plasma NA concentration was obtained, suggesting the pharmacological response can be reflected by plasma drug concentration. This correlation may be utilized for evaluating the pharmacological responses of various NA and its prodrug-based formulations with known plasma NA concentrations.",
keywords = "Controlled release, Microsphere, Nalbuphine propionate, Poly (d,l-lactide-co-glycolide)",
author = "Yen, {Shu Yang} and Sung, {K. C.} and Wang, {Jhi Joung} and {Yoa-Pu Hu}, Oliver",
year = "2001",
month = "6",
day = "4",
doi = "10.1016/S0378-5173(01)00649-4",
language = "English",
volume = "220",
pages = "91--99",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Controlled release of nalbuphine propionate from biodegradable microspheres

T2 - In vitro and in vivo studies

AU - Yen, Shu Yang

AU - Sung, K. C.

AU - Wang, Jhi Joung

AU - Yoa-Pu Hu, Oliver

PY - 2001/6/4

Y1 - 2001/6/4

N2 - The objective of this work was to assess the in vitro characteristics, in vivo pharmacokinetics and in vivo pharmacodynamics of nalbuphine propionate (NAP)-loaded microspheres. An oil-in-water solvent evaporation method was used to incorporate NAP into poly (d,l-lactide-co-glycolide) (PLGA)-based microspheres. The morphology of the microspheres were evaluated using scanning electron microscopy which showed a spherical shape with smooth surface. A prolonged in vitro drug release profile was observed, with ∼71.1% of incorporated drug released in 96 h. The release profile fit well to the Baker and Lonsdale's spherical matrix model, suggesting the release of NAP from microspheres was consistent with a diffusion mechanism. The in vivo pharmacokinetic studies after subcutaneous injection of NAP-loaded microsphere showed a sustained plasma nalbuphine (NA)-time profile, with 100% relative bioavailability comparing to the AUC obtained after intravenous injection. The in vitro release pattern correlated well with the in vivo pharmacokinetic profile. The pharmacodynamic studies evaluated using paw pressure model also showed a prolonged pharmacological response after injection of microspheres. A linear correlation between the percent analgesic effect and the logarithm of plasma NA concentration was obtained, suggesting the pharmacological response can be reflected by plasma drug concentration. This correlation may be utilized for evaluating the pharmacological responses of various NA and its prodrug-based formulations with known plasma NA concentrations.

AB - The objective of this work was to assess the in vitro characteristics, in vivo pharmacokinetics and in vivo pharmacodynamics of nalbuphine propionate (NAP)-loaded microspheres. An oil-in-water solvent evaporation method was used to incorporate NAP into poly (d,l-lactide-co-glycolide) (PLGA)-based microspheres. The morphology of the microspheres were evaluated using scanning electron microscopy which showed a spherical shape with smooth surface. A prolonged in vitro drug release profile was observed, with ∼71.1% of incorporated drug released in 96 h. The release profile fit well to the Baker and Lonsdale's spherical matrix model, suggesting the release of NAP from microspheres was consistent with a diffusion mechanism. The in vivo pharmacokinetic studies after subcutaneous injection of NAP-loaded microsphere showed a sustained plasma nalbuphine (NA)-time profile, with 100% relative bioavailability comparing to the AUC obtained after intravenous injection. The in vitro release pattern correlated well with the in vivo pharmacokinetic profile. The pharmacodynamic studies evaluated using paw pressure model also showed a prolonged pharmacological response after injection of microspheres. A linear correlation between the percent analgesic effect and the logarithm of plasma NA concentration was obtained, suggesting the pharmacological response can be reflected by plasma drug concentration. This correlation may be utilized for evaluating the pharmacological responses of various NA and its prodrug-based formulations with known plasma NA concentrations.

KW - Controlled release

KW - Microsphere

KW - Nalbuphine propionate

KW - Poly (d,l-lactide-co-glycolide)

UR - http://www.scopus.com/inward/record.url?scp=0035806317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035806317&partnerID=8YFLogxK

U2 - 10.1016/S0378-5173(01)00649-4

DO - 10.1016/S0378-5173(01)00649-4

M3 - Article

C2 - 11376971

AN - SCOPUS:0035806317

VL - 220

SP - 91

EP - 99

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -